Related references
Note: Only part of the references are listed.Antiplasmodial Compounds from Deep-Water Marine Invertebrates
Amy E. Wright et al.
MARINE DRUGS (2021)
Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites
Nanika Coetzee et al.
SCIENTIFIC REPORTS (2020)
Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance
Luana C. Mathieu et al.
ELIFE (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
Immunofluorescence staining protocol for STED nanoscopy of Plasmodium-infected red blood cells
Ann-Kathrin Mehnert et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2019)
Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum
Abhishek Kanyal et al.
FEBS JOURNAL (2018)
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites
Daniela Diedrich et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
Manel Ouji et al.
PARASITE (2018)
Histone 4 lysine 8 acetylation regulates proliferation and host-pathogen interaction in Plasmodium falciparum
Archana P. Gupta et al.
EPIGENETICS & CHROMATIN (2017)
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth
Ming Jang Chua et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2017)
Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach
Kai-Cheng Hsu et al.
SCIENTIFIC REPORTS (2017)
Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8
Nicholas J. Porter et al.
ACS CHEMICAL BIOLOGY (2017)
Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
Mohamed D. M. Traore et al.
ACS OMEGA (2017)
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
Erik L. Allman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite
Giuseppe Giannini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors
Jelena Melesina et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer et al.
SCIENCE (2015)
An Overview of Naturally Occurring Histone Deacetylase Inhibitors
Bumki Kim et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Epigenetic regulation of the Plasmodium falciparum genome
Michael F. Duffy et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2014)
Discovery of Potent HDAC Inhibitors Based on Chlamydocin with Inhibitory Effects on Cell Migration
Shimiao Wang et al.
CHEMMEDCHEM (2014)
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages
Finn K. Hansen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
A Potent HDAC Inhibitor, 1-Alaninechlamydocin, from a Tolypocladium sp Induces G2/M Cell Cycle Arrest and Apoptosis in MIA PaCa-2 Cells
Lin Du et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Magnetic isolation of Plasmodium falciparum schizonts iRBCs to generate a high parasitaemia and synchronized in vitro culture
Lydia Mata-Cantero et al.
MALARIA JOURNAL (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
An improved single-step lysis protocol to measure luciferase bioluminescence in Plasmodium falciparum
Sandra Hasenkamp et al.
MALARIA JOURNAL (2012)
Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group
Chris J. Vickers et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Ex Vivo Activity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates of Plasmodium falciparum and P-vivax
Jutta Marfurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
Histone deacetylase inhibition redistributes topoisomerase II beta from heterochromatin to euchromatin
Ian G. Cowell et al.
NUCLEUS (2011)
AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
Satoshi Sasamura et al.
JOURNAL OF ANTIBIOTICS (2010)
A Moonlighting Function of Plasmodium falciparum Histone 3, Mono-Methylated at Lysine 9?
Yen-Hoon Luah et al.
PLOS ONE (2010)
Histone Deacetylases Play a Major Role in the Transcriptional Regulation of the Plasmodium falciparum Life Cycle
Balbir K. Chaal et al.
PLOS PATHOGENS (2010)
Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
Alexandre Bougdour et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Active genes at the nuclear pore complex
Angela Taddei
CURRENT OPINION IN CELL BIOLOGY (2007)
Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from α-aminosuberic acid
Pia Kahnberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
FR235222, a fungal metabolite, is a novel, immunosuppressant that inhibits mammalian histone deacetylase (HDAC) - II. Biological activities in animal models
H Mori et al.
JOURNAL OF ANTIBIOTICS (2003)
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents
KT Andrews et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2000)